GlassScriptPhysician profile
Ankur Kalra
NPI 1295042539
$21,378.41
in general payments reported to CMS, 2019-2025
30 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,137 · 2020: $151 · 2021: $164 · 2022: $4,408 · 2023: $10K · 2024: $3,651 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,638 · Consulting Fee: $3,900 · Food and Beverage: $2,912 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,638.00 |
| Consulting Fee | $3,900.00 |
| Food and Beverage | $2,911.77 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12,310.24 | 2022-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $4,000.00 | 2022 | |
| Edwards Lifesciences Corporation | $1,853.35 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $770.56 | 2021-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Boston Scientific Corporation | $555.92 | 2019-2024 | Avvigo Guidance System, Synergy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $353.13 | 2019-2024 | Lifevest |
| Abiomed | $333.44 | 2020-2024 | Impella |
| Medtronic, INC. | $227.18 | 2021-2022 | |
| Medtronic Vascular, INC. | $125.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $119.47 | 2021-2024 | Brilinta, Farxiga |
| Ge Healthcare | $102.52 | 2023 | |
| Janssen Scientific Affairs, LLC | $100.32 | 2022 | |
| Inari Medical, INC. | $78.14 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aop Health US, LLC | $77.80 | 2025 | Rapiblyk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.66 | 2019-2025 | Jardiance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $41.95 | 2023-2024 | |
| Pfizer INC. | $36.83 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $30.76 | 2024 | Arcalyst |
| Lilly USA, LLC | $29.43 | 2025 | Zepbound |
| Amgen INC. | $25.52 | 2019 | |
| Kestra Medical Technology Services, INC. | $22.04 | 2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $16.38 | 2019 | |
| Philips North America LLC | $16.38 | 2024 | (6571) Eagle Eye |
| Kiniksa Pharmaceuticals, LTD. | $16.33 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $15.70 | 2023 | Inpefa |
| Chiesi USA, INC. | $15.48 | 2024 | Kengreal |
| Scpharmaceuticals INC. | $13.08 | 2023 | |
| Biotronik INC. | $12.82 | 2023 | Pk Papyrus, Orsiro Mission |
| Portola Pharmaceuticals, LLC | $12.71 | 2020 | |
| Terumo Medical Corporation | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Kalra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.